Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas.
Franceschi E, Tosoni A, Bartolini S, Minichillo S, Mura A, Asioli S, Bartolini D, Gardiman M, Gessi M, Ghimenton C, Giangaspero F, Lanza G, Marucci G, Novello M, Silini EM, Zunarelli E, Paccapelo A, Brandes AA.
Franceschi E, et al. Among authors: minichillo s.
Eur J Cancer. 2020 Sep;137:10-17. doi: 10.1016/j.ejca.2020.06.018. Epub 2020 Jul 26.
Eur J Cancer. 2020.
PMID: 32721633